A former professor and vice provost for research at the Albany College of Pharmacy and Health Sciences in New York, falsified data in two published papers, according to findings from the U.S. Office of Research Integrity (ORI).
Shaker Mousa, who was also chairman and executive vice president of the Pharmaceutical Research Institute at Albany, already has at least 10 retractions and two corrections, by our count.
The falsified data appeared in “Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer,” which appeared in Nanomedicine in 2013, and “The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin,” which appeared in the Journal of Cardiovascular Pharmacology in 2005 and was retracted last September. ORI called for Mousa to request a correction or retraction of the Nanomedicine paper as well.
Continue reading Pharmaceutical researcher faked data in two papers, says federal watchdog